Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jun;13(6):1684–1691. doi: 10.1128/iai.13.6.1684-1691.1976

Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia.

A Corallini, G Barbanti-Brodano, M Portolani, P G Balboni, M P Grossi, L Possati, C Honorati, M La Placa, A Mazzoni, A Caputo, U Veronesi, S Orefice, G Cardinali
PMCID: PMC420820  PMID: 184044

Abstract

Sera from 1,279 patients with various diseases were examined for the presence of antibodies to BK virus (BKV) capsid antigens. The percentage of positive sera was comparable in all the diseases except rheumatoid arthritis and chronic nephropathies, where a slightly higher prevalence was found. Sera from 952 patients with tumors were examined for the presence of antibodies to BKV tumor and capsid antigens in comparison with a matched control group of 501 blood donors. Sera from 11 tumor patients (1.15%) and from 4 normal controls (0.80%) had antibodies to BKV tumor antigen. No higher prevalence of antibodies to BKV capsid antigens was found in any cancer type except in carcinomas of the urinary bladder, where the percentage of positive sera and of sera with high titers was higher than in other groups. BKV infection is discussed in relation to its possible connection with human non-neoplastic diseases as well as with human tumors and to its activation under conditions of immunosuppressive therapy.

Full text

PDF
1687

Images in this article

1688Image
on p.1688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHKENAZI A., MELNICK J. L. Induced latent infection of monkeys with vacuolating SV-40 Papova virus. Virus in kidneys and urine. Proc Soc Exp Biol Med. 1962 Nov;111:367–372. doi: 10.3181/00379727-111-27794. [DOI] [PubMed] [Google Scholar]
  2. BLACK P. H., ROWE W. P., TURNER H. C., HUEBNER R. J. A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS. Proc Natl Acad Sci U S A. 1963 Dec;50:1148–1156. doi: 10.1073/pnas.50.6.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baringer J. R. Human herpes simplex virus infections. Adv Neurol. 1974;6:41–51. [PubMed] [Google Scholar]
  4. Black P. H. The oncogenic DNA viruses: a review of in vitro transformation studies. Annu Rev Microbiol. 1968;22:391–426. doi: 10.1146/annurev.mi.22.100168.002135. [DOI] [PubMed] [Google Scholar]
  5. Coleman D. V., Gardner S. D., Field A. M. Human polyomavirus infection in renal allograft recipients. Br Med J. 1973 Aug 18;3(5876):371–375. doi: 10.1136/bmj.3.5876.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diamandopoulos G. T., Tevethia S. S., Rapp F., Enders J. F. Development of S and T antigens and oncogenicity in hamster embryonic cell lines exposed to SV40. Virology. 1968 Feb;34(2):331–336. doi: 10.1016/0042-6822(68)90243-2. [DOI] [PubMed] [Google Scholar]
  7. Dougherty R. M., DiStefano H. S. Isolation and characterization of a papovavirus from human urine. Proc Soc Exp Biol Med. 1974 Jun;146(2):481–487. doi: 10.3181/00379727-146-38131. [DOI] [PubMed] [Google Scholar]
  8. GIRARDI A. J., SWEET B. H., SLOTNICK V. B., HILLEMAN M. R. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med. 1962 Mar;109:649–660. doi: 10.3181/00379727-109-27298. [DOI] [PubMed] [Google Scholar]
  9. Gardner S. D., Field A. M., Coleman D. V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971 Jun 19;1(7712):1253–1257. doi: 10.1016/s0140-6736(71)91776-4. [DOI] [PubMed] [Google Scholar]
  10. Gardner S. D. Prevalence in England of antibody to human polyomavirus (B.k.). Br Med J. 1973 Jan 13;1(5845):77–78. doi: 10.1136/bmj.1.5845.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HABEL K., SILVERBERG R. J. Relationship of polyoma virus and tumor in vivo. Virology. 1960 Nov;12:463–476. doi: 10.1016/0042-6822(60)90167-7. [DOI] [PubMed] [Google Scholar]
  12. Habel K. Virus-induced tumor antigens. Curr Top Microbiol Immunol. 1967;41:85–99. doi: 10.1007/978-3-642-46062-3_4. [DOI] [PubMed] [Google Scholar]
  13. Jung M., Krech U., Price P. C., Pyndiah M. N. Evidence of chronic persistent infections with polyomaviruses (BK type) in renal transplant recipients. Arch Virol. 1975;47(1):39–46. doi: 10.1007/BF01315591. [DOI] [PubMed] [Google Scholar]
  14. Lecatsas G., Prozesky O. W., van Wyk J., Els H. J. Papova virus in urine after renal transplantation. Nature. 1973 Feb 2;241(5388):343–344. doi: 10.1038/241343a0. [DOI] [PubMed] [Google Scholar]
  15. Lerner A. M., Lauter C. B., Nolan D. C., Shippey M. J. Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1460–1466. doi: 10.3181/00379727-140-36696. [DOI] [PubMed] [Google Scholar]
  16. Lewis A. M., Wiese W. H., Rowe W. P. The presence of antibodies in human serum to early (T) adenovirus antigens. Proc Natl Acad Sci U S A. 1967 Mar;57(3):622–629. doi: 10.1073/pnas.57.3.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Major E. O., Di Mayorca G. Malignant transformation of BHK21 clone 13 cells by BK virus--a human papovavirus. Proc Natl Acad Sci U S A. 1973 Nov;70(11):3210–3212. doi: 10.1073/pnas.70.11.3210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mullarkey M. F., Hruska J. F., Takemoto K. K. Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis. J Virol. 1974 May;13(5):1014–1019. doi: 10.1128/jvi.13.5.1014-1019.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mäntyjärvi R. A., Meurman O. H., Vihma L., Berglund B. A human papovavirus (B.K.), biological properties and seroepidemiology. Ann Clin Res. 1973 Oct;5(5):283–287. [PubMed] [Google Scholar]
  20. Penn I., Halgrimson C. G., Starzl T. E. De novo malignant tumors in organ transplant recipients. Transplant Proc. 1971 Mar;3(1):773–778. [PMC free article] [PubMed] [Google Scholar]
  21. Penn I., Starzl T. E. A summary of the status of de novo cancer in transplant recipients. Transplant Proc. 1972 Dec;4(4):719–732. [PubMed] [Google Scholar]
  22. Penney J. B., Jr, Narayan O. Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun. 1973 Aug;8(2):299–300. doi: 10.1128/iai.8.2.299-300.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Portolani M., Barbanti-Brodano G., Placa M. L. Malignant transformation of hamster kidney cells by BK virus. J Virol. 1975 Feb;15(2):420–422. doi: 10.1128/jvi.15.2.420-422.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Portolani M., Marzocchi A., Barbanti-Brodano G., La Placa M. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol. 1974 Nov;7(4):543–546. doi: 10.1099/00222615-7-4-543. [DOI] [PubMed] [Google Scholar]
  25. Rapp F., Tevethia S. S., Rawls W. E., Melnick J. L. Production of antibodies to papovavirus SV40 tumor antigen in African green monkeys. Proc Soc Exp Biol Med. 1967 Jul;125(3):794–798. doi: 10.3181/00379727-125-32208. [DOI] [PubMed] [Google Scholar]
  26. Reese J. M., Reissing M., Daniel R. W., Shah K. V. Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy. Infect Immun. 1975 Jun;11(6):1375–1381. doi: 10.1128/iai.11.6.1375-1381.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  28. Shah K. V., Daniel R. W., Murphy G. Antibodies reacting to Simian virus 40 T antigen in human sera. J Natl Cancer Inst. 1973 Aug;51(2):687–690. [PubMed] [Google Scholar]
  29. Shah K. V., Daniel R. W., Strandberg J. D. Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J Natl Cancer Inst. 1975 Apr;54(4):945–950. [PubMed] [Google Scholar]
  30. Shah K. V., Daniel R. W., Warszawski R. M. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis. 1973 Dec;128(6):784–787. doi: 10.1093/infdis/128.6.784. [DOI] [PubMed] [Google Scholar]
  31. Shah K. V., Daniel R. W., Zeigel R. F., Murphy G. P. Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation. 1974 Jan 1;17(1):131–134. [PubMed] [Google Scholar]
  32. Shah K. V. Evidence for an SV40-related papovavirus infection of man. Am J Epidemiol. 1972 Mar;95(3):199–206. doi: 10.1093/oxfordjournals.aje.a121387. [DOI] [PubMed] [Google Scholar]
  33. Shah K. V., Hess D. M. Presence of antibodies to simian virus 40 (SV40) T antigen in rhesus monkeys infected experimentally or naturally with SV40. Proc Soc Exp Biol Med. 1968 Jun;128(2):480–485. doi: 10.3181/00379727-128-33043. [DOI] [PubMed] [Google Scholar]
  34. Shah K. V. Investigation of human malignant tumors in India for simian virus 40 etiology. J Natl Cancer Inst. 1969 Jan;42(1):139–145. [PubMed] [Google Scholar]
  35. Shah K. V., McCrumb F. R., Jr, Daniel R. W., Ozer H. L. Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst. 1972 Feb;48(2):557–561. [PubMed] [Google Scholar]
  36. Shah K. V., Ozer H. L., Pond H. S., Palma L. D., Murphy G. P. SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature. 1971 Jun 18;231(5303):448–449. doi: 10.1038/231448a0. [DOI] [PubMed] [Google Scholar]
  37. Shah K. V., Willard S., Myers R. E., Hess D. M., DiGiacomo R. Experimental infection of rhesus with simian virus 40 (SV40). Proc Soc Exp Biol Med. 1969 Jan;130(1):196–203. doi: 10.3181/00379727-130-33520. [DOI] [PubMed] [Google Scholar]
  38. Takemoto K. K., Mullarkey M. F. Human papovavirus, BK strain: biological studies including antigenic relationship to simian virus 40. J Virol. 1973 Sep;12(3):625–631. doi: 10.1128/jvi.12.3.625-631.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Takemoto K. K., Rabson A. S., Mullarkey M. F., Blaese R. M., Garon C. F., Nelson D. Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst. 1974 Nov;53(5):1205–1207. doi: 10.1093/jnci/53.5.1205. [DOI] [PubMed] [Google Scholar]
  40. Vonka V., Zavadova H., Kutinova L., Rezacova D. Development of antibodies against viral and tumor antigens of papovavirus SV40 in monkeys. Proc Soc Exp Biol Med. 1967 Jul;125(3):790–794. doi: 10.3181/00379727-125-32207. [DOI] [PubMed] [Google Scholar]
  41. Weiner L. P., Herndon R. M., Narayan O., Johnson R. T., Shah K., Rubinstein L. J., Preziosi T. J., Conley F. K. Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med. 1972 Feb 24;286(8):385–390. doi: 10.1056/NEJM197202242860801. [DOI] [PubMed] [Google Scholar]
  42. Weiss A. F., Portmann R., Fischer H., Simon J., Zang K. D. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci U S A. 1975 Feb;72(2):609–613. doi: 10.1073/pnas.72.2.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. ter Meulen V., Katz M., Müller D. Subacute sclerosing panencephalitis: a review. Curr Top Microbiol Immunol. 1972;57:1–38. doi: 10.1007/978-3-642-65297-4_1. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES